Taysha Gene Therapies, Inc. (TSHA) stock
TSHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.99−0.01 (-0.25%)
Close on Nov 18, 2026Market cap $1.30BP/E –Yield –
Taysha Gene Therapies market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Taysha Gene Therapies's market cap was $1.39B on Nov 11, 2026, against $1.30B a year earlier. Over the last 5 years it ranged from $41.96M to $1.96B, with a median of $397.59M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.39B | -7.6% |
| 2025 | Dec 31, 2025 | $1.51B | +324.9% |
| 2024 | Dec 31, 2024 | $354.55M | +7.1% |
| 2023 | Dec 29, 2023 | $330.92M | +255.6% |
| 2022 | Dec 30, 2022 | $93.06M | -79.2% |
| 2021 | Dec 31, 2021 | $448.22M | -55.3% |
| 2020 | Dec 31, 2020 | $1.00B | – |
See a number that looks wrong?